Related Experiment Video
Updated: May 16, 2026

14:15
Multicolor 3D Printing of Complex Intracranial Tumors in Neurosurgery
Published on: January 11, 2020
Skull base chondrosarcoma: evidence-based treatment paradigms.
1Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143-0112, USA.
Neurosurgery Clinics of North America
|November 24, 2012
Summary
This review examines surgical and radiation strategies for skull base chondrosarcoma. It assesses how surgical extent and various radiation therapies impact patient outcomes in treating this rare bone cancer.
Area of Science:
- Oncology
- Neurosurgery
- Radiation Oncology
Background:
- Skull base chondrosarcomas are slow-growing but invasive bone cancers.
- Current treatment involves surgery and radiation therapy.
Purpose of the Study:
- To review the impact of surgical approach and resection extent on outcomes for skull base chondrosarcoma.
- To evaluate the efficacy of different radiation modalities in controlling tumor growth.
- To discuss emerging therapies for skull base chondrosarcoma.
Main Methods:
- Literature review of surgical and radiation treatment for skull base chondrosarcoma.
- Analysis of evidence on the importance of surgical extent and resection.
- Evaluation of conventional fractionated radiotherapy, proton beam, and stereotactic radiosurgery efficacy.
Main Results:
- Surgical approach and extent of resection significantly influence outcomes.
- Various radiation therapy modalities demonstrate varying degrees of tumor growth control.
- Emerging therapies show promise for future treatment strategies.
Conclusions:
- Optimizing surgical resection and selecting appropriate radiation techniques are crucial for managing skull base chondrosarcoma.
- Further research into novel therapeutic approaches is warranted.
Related Concept Videos
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
